Fibroblasts and Induced Pluripotent Stem Cells (iPSC) for Parkinson’s Disease Research:
The NINDS has created a fibroblast and induced pluripotent stem cell (iPSC) resource for Parkinson’s Disease research that is available through the NINDS repository at the Coriell Institute for Medical Research. Fibroblast lines currently available for distribution include: alpha-synuclein triplication, LRRK2 mutations, parkin mutations, PINK1 mutations, GBA and others including fibroblast lines for idiopathic PD patients. Available iPSC lines currently include alpha-synuclein triplication, LRRK2 and parkin mutations. Control lines are also available.
Please note the following NINDS policy on applications proposing development of iPSC lines: NOT-NS-14-032
Point of Contact: Margaret Sutherland, Ph.D., Program Director
Last updated May 27, 2014